TT vs ZBIO · P/E 36, rev $11.32B vs rev $10.0M
Trane Technologies plc (TT) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
TT currently screens at market cap $104.45B and trailing P/E 36.2. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the TT and ZBIO stock pages for the full models.
Not investment advice.